DR info

Clinical trials : 42 / Drugs : 33 - (DrugBank : 11) / Drug target genes : 12 - Drug target pathways : 123

Inclusion body myositis and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability

ID	Diseases (Sorted by drug repositionability)
15	Inclusion body myositis
46	Malignant rheumatoid arthritis
13	Multiple sclerosis/Neuromyelitis optica
86	Pulmonary arterial hypertension
49	Systemic lupus erythematosus
97	Ulcerative colitis
2	Amyotrophic lateral sclerosis
56	Behcet disease
84	Sarcoidosis
65	Primary immunodeficiency
96	Crohn disease
94	Primary sclerosing cholangitis
50	Dermatomyositis
107	Juvenile idiopathic arthritis
298	Hereditary pancreatitis
222	Primary nephrotic syndrome
28	Systemic amyloidosis
19	Lysosomal storage disease
299	Cystic fibrosis
51	Scleroderma
6	Parkinson disease
280	Huge arteriovenous malformation with cervicofacial or limb lesion
106	Cryopyrin-associated periodic syndrome
37	Generalised pustular psoriasis
35	Pemphigus
285	Fanconi anemia
228	Bronchiolitis obliterans
41	Giant cell arteritis
137	Focal cortical dysplasia
192	Cockayne syndrome
277	Lymphangiomatosis
281	Klippel-Trenaunay-Weber syndrome